DrugDashboards

Dexamethasone Sodium Phosphate

Dexamethasone Sodium Phosphate · DEXAMETHASONE SODIUM PHOSPHATE 10 mg/mL · Injection, Emulsion · Intramuscular; Intravenous · Fresenius Kabi USA, LLC

NDC 76045-0109-10 · 24 BLISTER PACK in 1 CARTON / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. It is in shortage right now — FDA lists the reason as “demand increase for the drug”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Medicare Part B pays (ASP+6%)$0.0850per billing unit (1 MG)HCPCS J1100 · Jul 1, 2026
  • Part D plans paid (avg)$2.89per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$69.95per package of 24X1MLFresenius Kabi, LLC · May 15, 2025

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$138.72
Reported to Texas DSHS · 2026 annual filing · Fresenius Kabi USA

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 1 MG
$0.085
HCPCS J1100 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$4,382
1,427 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for dexamethasone sodium phosphate (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $14.09 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA209192
TE code
AP
Approval date
Jul 6, 2018
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-0212-10)Feb 8, 2019
    Demand increase for the drug
    month 91 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-109-10)Feb 8, 2019
    Demand increase for the drug
    month 91 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-212-10)Feb 8, 2019
    Demand increase for the drug
    month 91 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Dexamethasone Sodium Phosphate (Injection, Emulsion)

LabelerStrengthFirst seenLast seen
Fresenius Kabi USA, LLCDEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Dexamethasone Sodium Phosphate — NDC 76045-0109-10," retrieved September 3, 2026, https://drugdashboards.com/drug/76045010910.

Free to cite with attribution — see how the data is put together.